Novavax Highlights Vaccine Innovations and Global Health Commitment at Jefferies London Conference

Novavax Showcases Commitment to Global Health at Jefferies London Healthcare Conference

Novavax, Inc. (Nasdaq: NVAX) prepares to engage with stakeholders at the upcoming Jefferies London Healthcare Conference on November 19, 2025. Scheduled for 4:30 p.m. Greenwich Mean Time, this event provides a platform for the company to present its innovative advancements in vaccine technology. The conference will include a fireside chat, and the proceedings will be accessible via a webcast on Novavax's Events & Presentations page for one month post-event. This initiative emphasizes Novavax's dedication to transparency and its commitment to addressing critical global health challenges through cutting-edge vaccine solutions.

At the heart of Novavax's strategy is its advanced vaccine technology, which employs protein-based nanoparticles and the proprietary Matrix-M® adjuvant. These innovations aim to enhance vaccine efficacy and safety, allowing for more effective responses to infectious diseases. By leveraging its technological strengths, Novavax focuses on optimizing existing partnerships while expanding its research and development efforts. This dual approach not only bolsters the company’s position in the biotech sector but also aligns with its mission to provide innovative solutions to pressing health needs worldwide.

The company's participation in the Jefferies conference underscores its proactive stance in communicating its strategies and advancements to a broader audience, including investors, healthcare professionals, and the public. Novavax's ongoing efforts to engage with stakeholders reflect its understanding of the importance of collaboration in the biopharmaceutical industry. By fostering new partnerships and enhancing its technological platform, Novavax aims to improve access to its vaccine technologies, ultimately contributing to better health outcomes for populations globally.

In addition to the conference, Novavax continues to encourage interested parties to explore its website for updates on its initiatives and future events. This commitment to engagement highlights the company's transparent approach and readiness to discuss its contributions to global health advancements. For inquiries, stakeholders can reach out to designated contacts for investor relations and media to gain further insights into Novavax's operations and strategic focus.